TAG ARCHIVES FOR Drug Prices

2
Jun2017

This week’s Research Ethics Roundup reviews a Congressional hearing on reducing overhead payments for research oversight, highlights doctors’ arguments for saving the Fogarty International Center at the National Institute of Health (NIH), discusses legal challenges faced by the US Department of Agriculture (USDA) over their decision to delay reposting animal welfare records, and outlines a proposal that allow human subjects to negotiate with the pharmaceutical industry on drug pricing issues.

House Science Panel Joins Trump in Questioning Research Overhead Payments
Jeffrey Mervis reports for Science on a recent Congressional hearing in which representatives reviewed the [...] Read more

13
Jan2017

This week’s Research Ethics Roundup reviews the complex issues surrounding clinical trials and infants, concerns about publications not including all of a study’s adverse events, and the vice president’s new “cancer moonshot” nonprofit. Read more